S

Spyre Therapeutics

Clinical-stage biotech antibodies for IBD

Director Drug Safety Physician

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • An MD and at least 6 years of related clinical development drug safety or medical review experience in the biotechnology or pharmaceutical industry, including medical review of Individual Case Safety Reports and periodic reports.
  • Working experience or proficiency with the Argus global safety database and medical review activities.
  • Working experience in safety surveillance and signal detection activities.
  • Knowledge of global pharmacovigilance regulations, including EMA and FDA requirements, relevant to the role's activities.
  • Analytical and problem-solving skills to interpret complex data and translate findings into actionable drug development strategies.
  • Communication and interpersonal skills to collaborate effectively across functions.

Responsibilities

  • Perform triage and medical review of Individual Case Safety Reports, in or outside the global safety database, and oversee cases and Analysis of Similar Events for expedited safety reporting.
  • Lead cross-functional medical review discussions pertaining to Individual Case Safety Report review.
  • Participate in preparing, writing, and/or reviewing aggregate safety review documents, including DSURs, and safety sections of relevant clinical trial documents and regulatory filings.
  • Participate in and/or lead scientific literature reviews, including preparing written summaries to support aggregate safety analyses.
  • Participate in safety data review, including safety surveillance and evaluation and management of safety signals emerging from any data source.
  • Participate and co-present cases at safety management team and safety review team meetings, and co-lead safety surveillance and signal management meetings.
  • Participate in process improvement projects related to medical review and assessment, safety surveillance, and relevant aspects of pharmacovigilance compliance.
  • Assist the DSPV department head in developing and maintaining pharmacovigilance processes and procedures, including SOPs, work instructions, safety management plans, and safety surveillance plans.
  • Participate in safety presentation development for independent Data Monitoring Committee meetings.
  • Collaborate with the Medical Review Lead and other physicians on ongoing case reviews, a unified approach to medical review of Individual Case Safety Reports, safety presentations, and input into study protocols, periodic safety reports, and safety management plans.
  • Lead epidemiology projects relevant to safety and pharmacovigilance, including natural history of disease, comorbidities, class effects, population health data, real-world drug safety monitoring, literature searches, signal detection and data mining, and comparative effectiveness and safety research.
  • Execute assigned activities efficiently and with quality, accuracy, and timeliness in accordance with current global regulatory requirements.
  • Provide medical safety strategy and execute benefit-risk management strategies for assigned products.
  • Provide safety input to clinical development plans and responses to health authority or institutional review board/ethics committee queries.
  • Provide input into safety risk language, risk management strategy, pre-filing safety activities including safety table shells, integrated safety data review, integrated safety summary document review, and safety-focused publication development.
  • Perform other duties as assigned.

Desired Qualifications

  • A degree in epidemiology, such as a Master's in Public Health, Master's of Science in Epidemiology, Doctor of Philosophy in Epidemiology, or Doctor of Public Health, or several years of working knowledge in epidemiology or pharmacoepidemiology.
  • Two to three years of medical device safety experience.

About the Company

Spyre Therapeutics

Clinical-stage biotech antibodies for IBD

Spyre Therapeutics develops long-acting antibody therapies for inflammatory bowel disease (IBD), targeting ulcerative colitis and Crohn’s disease with programs such as anti-α4β7 and anti-TL1A. These antibodies are designed to inhibit immune pathways in the gut to reduce inflammation and are built for durable effects, aiming for patient-friendly dosing and potential combo-therapy use. Unlike some peers, Spyre focuses on best-in-class antibodies with durability and a diversified pipeline, shifting away from its past enzyme programs toward immunology-driven treatments for large GI markets. The company aims to discover, develop, and potentially commercialize antibody therapies that address unmet needs in IBD and improve long-term patient outcomes.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Spyre Therapeutics

See more jobs